This proposal will investigate the effect of age on propranolol steroselective disposition and response in man. Beta-receptors in the elderly appear to have a diminished in-vivo affinity for propranolol. Evidence for a change in propranolol binding to these receptors, however, has been based upon the relationship between total racemic drug levels and effect. Little is known about the influence of age on the steroselective disposition of propranolol, even though changes in its enantiomeric composition in-vivo could alter its response and influence conclusions about the diminished affinity of beta-receptors for propranolol in the aged. Recent evidence has shown the steroselective disposition of hexobarbital is altered by age in man and the possibility exists that other racemic drugs, like propranolol, may also be affected. More detailed cross-sectional studies of age related effects on propranolol steroselective disposition and in-vivo binding to beta- receptors in man are proposed which will define both the extent and rate change in these parameters with age. The specific hypothesis to be tested is: An age associated alteration in the enantiomeric disposition of propranolol occurs in man which contributes to the apparent altered sensitivity of the elderly to this drug. The testing of this hypothesis will involve a multidisciplinary team with expertise in analytical methods, protein binding and clinical procedures. This research should provide valuable basic information by delineating the influence of age on the steroselective disposition and response to propranolol.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG007478-01A1
Application #
3118631
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1988-08-01
Project End
1991-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
Schools of Pharmacy
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Colangelo, P M; Blouin, R A; Steinmetz, J E et al. (1992) Age and beta-adrenergic receptor sensitivity to S(-)- and R,S(+/-)-propranolol in humans. Clin Pharmacol Ther 51:549-54
Colangelo, P M; Blouin, R A; Steinmetz, J E et al. (1992) Age and propranolol stereoselective disposition in humans. Clin Pharmacol Ther 51:489-94
Britto, M R; McKean, H E; Bruckner, G G et al. (1991) Polymorphisms in oxidative drug metabolism: relationship to food preference. Br J Clin Pharmacol 32:235-7
Zhang, Y; Blouin, R A; McNamara, P J et al. (1991) Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies. Br J Clin Pharmacol 31:350-2
Hallak, H O; Wedlund, P J (1991) Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats. Drug Metab Dispos 19:278-9
Guttendorf, R J; Kostenbauder, H B; Wedlund, P J (1991) Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats. Drug Metab Dispos 19:251-6
Akrawi, S H; Wedlund, P J (1990) Mephenytoin stereoselective elimination in the rat: III. Stereoselective time course of induction during chronic hepatic portal vein administration. Eur J Drug Metab Pharmacokinet 15:245-51